Gynaec Oncology

Human papillomavirus (HPV) screening plays a crucial role in preventing cervical cancer by identifying high-risk infections early. However, the accuracy and effectiveness of screening programs can be affected by a phenomenon known as enrichment bias. This bias can distort the interpretation of screening results, leading to potential mismanagement of patient care. This post explores the concept of enrichment bias in HPV screening, focusing on the distinction between accumulate

Human papillomavirus (HPV) plays a central role in the development of cervical cancer, a disease that remains a significant health challenge worldwide. Not all HPV infections carry the same risk, and individual host factors further influence the likelihood of progression to cancer. This blog post explores how host characteristics and specific HPV genotypes affect cervical cancer risk, highlighting the importance of personalized screening strategies. Recent research findings w

Endometriosis and ovarian cancer are significant concerns in women's health, with growing evidence suggesting a connection between these two conditions. Understanding this link is crucial for improving diagnosis, treatment, and patient outcomes. This article reviews the epidemiological data, molecular mechanisms, and clinical strategies that shed light on how endometriosis may influence ovarian cancer risk.

Cervical cancer remains a significant health challenge worldwide, with early-stage disease often managed through radical surgery. However, recent advances in understanding tumor biology and patient outcomes have sparked interest in de-escalating surgical treatment for select patients with FIGO Stage I cervical cancer. This approach aims to reduce treatment-related morbidity without compromising cancer control. This article explores the rationale behind de-escalation, criteria

Cancer treatments have improved survival rates dramatically, but many female survivors face challenges related to fertility. Understanding how cancer and its treatment affect reproductive lifespan is crucial for survivors and healthcare providers planning for family building. One key tool in this assessment is the measurement of Anti-Müllerian Hormone (AMH), a hormone that reflects ovarian reserve and fertility potential. This post explores how AMH helps evaluate fertility in

Menopause brings significant changes to a woman’s body, and for gynecologic cancer survivors, these changes can be even more complex. The FIGO Committee recently released a position paper addressing menopausal hormone therapy (MHT) and postmenopausal care specifically for this group. Their findings highlight the importance of personalized care that balances benefits and risks while supporting survivors’ quality of life. This post explores the key insights from the paper and o

Cervical cancer remains a leading cause of cancer-related deaths among women in Rwanda and many low-resource settings. Early detection through regular screening is critical to reducing mortality, yet participation rates remain low. Mobile phone penetration in Rwanda offers a promising channel to reach women with health messages. This blog post examines a pilot study that explored the feasibility of using SMS (Short Message Service) to recruit women for cervical cancer screeni

Gestational trophoblastic neoplasia (GTN) represents a group of rare tumors that arise from abnormal growth of trophoblastic tissue, which normally forms part of the placenta during pregnancy. Accurate diagnosis and effective management of GTN depend heavily on proper staging. The International Federation of Gynecology and Obstetrics (FIGO) staging system plays a crucial role in this process. It helps clinicians classify the disease, predict prognosis, and guide treatment dec

Low-risk cervical cancer presents a unique challenge in balancing effective treatment with minimizing patient morbidity. Surgical intervention remains a cornerstone of management, but the choice of surgical approach can significantly influence oncologic outcomes. Recent studies have shed light on how different techniques affect survival rates, recurrence, and overall patient prognosis. This post explores key findings from a pivotal study analyzing the association between surg

Staying current with clinical guidelines and research is essential for effective practice in obstetrics and gynecology. The rapid pace of medical advancements requires a reliable source that consolidates updates and recommendations. This clinical OB-GYN blog aims to provide concise, practical information to support decision-making and patient care.

Staying current with clinical guidelines is essential for effective practice in obstetrics and gynecology. The Federation of Obstetric and Gynaecological Societies of India (FOGSI) regularly updates its recommendations to reflect new research and clinical evidence. Accessing these guidelines online saves time and ensures you apply the most recent standards in patient care. This post guides you through the latest FOGSI guidelines, how to access them, and key updates relevant t

The landscape of women's health is constantly evolving, with new guidelines and recommendations emerging from leading organizations like the American College of Obstetricians and Gynecologists (ACOG) and the Royal College of Obstetricians and Gynaecologists (RCOG). Staying updated with these changes is crucial for healthcare professionals who aim to provide the best care for their patients. This blog post will delve into the latest updates from ACOG and RCOG, highlighting key